IPOSchedule
EN
EnglishDeutschFrançais
ADARx PharmaceuticalsFinal pricing

ADARx Pharmaceuticals prices its IPO

IPOSchedulePublished Updated

ADARx Pharmaceuticals prices its IPO (September 24, 2026).

ADARx Pharmaceuticals develops siRNA therapeutics intended to treat a range of diseases.

Pricing announcement (28 Sept 2026)

Offering details

Offer price
$17.0
Shares offered
26.3M
Exchange
Nasdaq Global Select Market
Proposed ticker
ADRX
Offering size
$446.3M
Pricing announcement (28 Sept 2026)

Updates

  1. Added: Company description, Exchange, Proposed ticker

    Company description: ADARx Pharmaceuticals develops siRNA therapeutics intended to treat a range of diseases.

    Exchange: Nasdaq Global Select Market

    Proposed ticker: ADRX